Structures by: Johnstone R. D.
Total: 58
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3344(6)Å b=11.822(3)Å c=4.7387(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3563(6)Å b=11.443(2)Å c=4.6166(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3706(6)Å b=11.204(2)Å c=4.5341(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.3728(5)Å b=11.0359(17)Å c=4.4782(3)Å
α=90° β=90° γ=90°
Serine Monohydrate
C3H9N1O4
CrystEngComm (2008) 10, 12 1758
a=9.8778(13)Å b=10.155(4)Å c=4.4175(7)Å
α=90° β=90° γ=90°
Serine hydrate
C3D7NO3,D2O1
CrystEngComm (2008) 10, 12 1758
a=9.3701(14)Å b=11.1831(10)Å c=4.52938(59)Å
α=90° β=90° γ=90°
Serine hydrate
C3D7NO3,D2O1
CrystEngComm (2008) 10, 12 1758
a=9.8641(14)Å b=10.09910(93)Å c=4.39860(65)Å
α=90° β=90° γ=90°
C32H42Cu1N10O10Ru1
C32H42Cu1N10O10Ru1
Dalton transactions (Cambridge, England : 2003) (2007) 27 2942-2948
a=17.399(5)Å b=13.501(4)Å c=14.678(5)Å
α=90° β=90.611(15)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.8887(8)Å b=4.9700(3)Å c=20.9607(19)Å
α=90° β=91.546(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.7925(11)Å b=4.9356(5)Å c=20.415(5)Å
α=90° β=92.266(14)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.5438(6)Å b=4.8464(3)Å c=19.203(3)Å
α=90° β=93.648(7)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.3706(7)Å b=4.7918(3)Å c=18.398(3)Å
α=90° β=94.078(8)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.2791(7)Å b=4.7643(3)Å c=17.9649(17)Å
α=90° β=93.960(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=3.8938(4)Å b=5.5612(6)Å c=28.566(8)Å
α=90° β=90° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6168(2)Å b=15.2552(5)Å c=52.3376(16)Å
α=90° β=89.976(2)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.3592(7)Å b=14.601(2)Å c=51.188(9)Å
α=90° β=89.989(10)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.2634(3)Å b=14.4120(11)Å c=50.836(4)Å
α=90° β=89.966(5)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6837(2)Å b=15.5843(6)Å c=52.1546(16)Å
α=90° β=89.933(2)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.1346(6)Å b=14.165(2)Å c=50.433(8)Å
α=90° β=89.880(9)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.701(2)Å b=12.569(6)Å c=24.786(13)Å
α=90° β=90° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.0316(6)Å b=14.0254(19)Å c=50.157(8)Å
α=90° β=89.796(9)° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6475(7)Å b=12.451(3)Å c=24.651(2)Å
α=90° β=90° γ=90°
Methyl 2-(9H-carbazol-9-yl)benzoate
C20H15N1O2
CrystEngComm (2010) 12, 9 2520
a=7.6285(8)Å b=12.299(3)Å c=24.555(3)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.4715(4)Å b=11.4963(5)Å c=13.0802(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.431(3)Å b=11.438(7)Å c=13.018(3)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.0252(5)Å b=11.0298(14)Å c=12.3350(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.1517(6)Å b=11.1659(16)Å c=12.5744(7)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.9440(5)Å b=10.9336(14)Å c=12.1698(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.8854(5)Å b=10.8632(14)Å c=12.0516(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.8458(5)Å b=10.8143(14)Å c=11.9708(6)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.8188(6)Å b=10.7838(17)Å c=11.9105(8)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.7881(13)Å b=10.735(2)Å c=11.859(2)Å
α=90° β=90° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.778(2)Å b=10.656(4)Å c=11.884(3)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.9233(2)Å b=19.0222(5)Å c=5.3030(2)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.8922(2)Å b=19.0021(19)Å c=5.2919(2)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.7622(2)Å b=18.7945(19)Å c=5.2343(2)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.5490(3)Å b=18.259(3)Å c=5.1169(3)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4955(4)Å b=18.000(4)Å c=5.0930(4)Å
α=90° β=90° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4885(14)Å b=17.834(7)Å c=5.0983(13)Å
α=90° β=90° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.4946(4)Å b=7.6198(3)Å c=11.5599(17)Å
α=90° β=93.306(7)° γ=90°
L-Cysteic acid monohydrate
C3H9N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.6284(3)Å b=18.508(3)Å c=5.1615(3)Å
α=90° β=90° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.3782(3)Å b=7.4754(3)Å c=11.4450(13)Å
α=90° β=92.591(7)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=10.2176(8)Å b=8.2463(5)Å c=12.6853(17)Å
α=90° β=114.238(9)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.9602(9)Å b=8.1894(6)Å c=12.475(2)Å
α=90° β=113.060(11)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.7934(8)Å b=8.1603(5)Å c=12.3534(17)Å
α=90° β=112.384(9)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.7046(5)Å b=8.1477(3)Å c=12.3071(13)Å
α=90° β=112.034(6)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.6213(11)Å b=8.1290(8)Å c=12.298(3)Å
α=90° β=112.049(13)° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=9.5437(17)Å b=8.1824(12)Å c=12.151(4)Å
α=90° β=111.30(2)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=10.1860(3)Å b=8.4277(2)Å c=11.6457(3)Å
α=90° β=109.591(2)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.9825(11)Å b=7.8892(15)Å c=11.4879(9)Å
α=90° β=109.780(6)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.9021(14)Å b=7.6543(18)Å c=11.4225(11)Å
α=90° β=109.860(9)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.8354(13)Å b=7.4567(19)Å c=11.3543(12)Å
α=90° β=109.939(8)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7854(7)Å b=7.2988(11)Å c=11.3074(7)Å
α=90° β=110.028(4)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7527(9)Å b=7.2058(15)Å c=11.2786(9)Å
α=90° β=110.132(6)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7286(10)Å b=7.1123(17)Å c=11.2468(11)Å
α=90° β=110.186(7)° γ=90°
Bianthrone
C28H16O2
Acta Crystallographica Section B (2011) 67, 3 226-237
a=9.7119(14)Å b=7.041(2)Å c=11.2282(18)Å
α=90° β=110.229(10)° γ=90°
Betaine monohydrate
C5H13N1O3
Acta Crystallographica Section B (2009) 65, 6 731-748
a=8.7873(10)Å b=10.710(2)Å c=11.8632(12)Å
α=90° β=90° γ=90°
S-4-Sulfo-L-Phenylalanine monohydrate
C9H13N1O6S1
Acta Crystallographica Section B (2009) 65, 6 731-748
a=6.5299(5)Å b=7.6432(6)Å c=11.6081(9)Å
α=90° β=93.590(5)° γ=90°